JayaBio News
Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio
U.S. patent grant broadens protection and strengthens Jaya Biosciences’ leadership in developing CNS- directed therapies for genetically defined neurodegenerative diseases
Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s
Patent allowances in Japan, China and Singapore support Jaya Biosciences’ commitment to addressing unmet needs in neurodegeneration in global markets
Jaya Biosciences Executive Team Meets with South Carolina Government
Our executive team had the honor of meeting with Hon. Lieutenant Governor of South Carolina, Pamela Everette.
Jaya Biosciences Completes Inaugural SCbioDrive Accelerator Program
We are proud to announce the successful completion of SCbioDrive, an accelerator program for emerging life sciences companies organized by SCbio in partnership with MassBio. JayaBio was one of seven oncology and neuroscience startups selected to be a part of the inaugural cohort.